Wearable Health Solutions (WHSI) Ratios
Wearable Health Solutions Ratios
WHSI's free cash flow for Q2 2024 was $-10.25K. For the 2024 fiscal year, WHSI's free cash flow was increased by $0.00 and operating cash flow was $-10.25K. See a summary of the company’s cash flow.
| Ratios | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.04 | 0.12 | 0.21 | 0.09 | 0.15 |
| Quick Ratio | 0.04 | 0.09 | 0.21 | 0.04 | 0.10 |
| Cash Ratio | 0.04 | 0.03 | 0.20 | 0.00 | 0.03 |
| Solvency Ratio | -0.63 | -5.37 | -0.78 | -0.15 | -0.07 |
| Operating Cash Flow Ratio | -0.34 | -1.28 | -0.28 | -0.20 | -0.00 |
| Short-Term Operating Cash Flow Coverage | -0.47 | -1.62 | -0.44 | -0.39 | -0.00 |
| Net Current Asset Value | $ -3.65M | $ -2.13M | $ -3.35M | $ -2.72M | $ -1.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 12.40 | 5.66 | 2.93 | 2.70 | 4.25 |
| Debt-to-Equity Ratio | -0.77 | -0.92 | -0.79 | -0.76 | -0.78 |
| Debt-to-Capital Ratio | -3.42 | -11.02 | -3.85 | -3.16 | -3.45 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -0.21 | -0.33 |
| Financial Leverage Ratio | -0.06 | -0.16 | -0.27 | -0.28 | -0.18 |
| Debt Service Coverage Ratio | -0.79 | -6.49 | -1.07 | -0.51 | -0.46 |
| Interest Coverage Ratio | -19.89 | -162.48 | -14.29 | -2.42 | -1.15 |
| Debt to Market Cap | 1.27 | 0.12 | 0.46 | 0.83 | 0.85 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | -1.16 | -0.14 | -0.59 | -1.65 | -2.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.92% | 45.65% | 37.64% | 59.57% | 75.78% |
| EBIT Margin | -305.08% | -1239.98% | -221.76% | -91.30% | -42.82% |
| EBITDA Margin | -303.42% | -1239.19% | -221.32% | -90.66% | -42.08% |
| Operating Profit Margin | -307.90% | -1247.22% | -226.78% | -42.61% | -4.14% |
| Pretax Profit Margin | -320.56% | -1247.66% | -237.64% | -39.01% | -8.59% |
| Net Profit Margin | -320.56% | -1248.10% | -237.64% | -39.01% | -13.04% |
| Continuous Operations Profit Margin | -320.56% | -1247.66% | -237.64% | 0.00% | -70.49% |
| Net Income Per EBT | 100.00% | 100.04% | 100.00% | 100.00% | 151.82% |
| EBT Per EBIT | 104.11% | 100.04% | 104.79% | 91.56% | 207.57% |
| Return on Assets (ROA) | -1070.23% | -3849.98% | -364.95% | -70.44% | -45.25% |
| Return on Equity (ROE) | 66.77% | 623.92% | 98.89% | 19.79% | 8.26% |
| Return on Capital Employed (ROCE) | 64.47% | 623.48% | 94.37% | 26.14% | 2.62% |
| Return on Invested Capital (ROIC) | 283.32% | 7495.25% | 457.68% | 37.28% | 6.81% |
| Return on Tangible Assets | -1070.23% | -3849.98% | -364.95% | -70.44% | -45.25% |
| Earnings Yield | -111.16% | -80.13% | -57.20% | -21.72% | -8.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1965.94 | 522.95 | 50.34 | 30.38 | 82.61 |
| Payables Turnover | 2.93 | 9.81 | 2.62 | 1.73 | 1.10 |
| Inventory Turnover | 55.81 | 8.23 | 38.33 | 4.36 | 2.52 |
| Fixed Asset Turnover | 10.52 | 25.11 | 0.00 | 0.00 | 165.91 |
| Asset Turnover | 3.34 | 3.08 | 1.54 | 1.81 | 3.47 |
| Working Capital Turnover Ratio | -0.26 | -0.38 | -0.49 | -0.59 | -0.65 |
| Cash Conversion Cycle | -117.84 | 7.87 | -122.55 | -115.48 | -181.56 |
| Days of Sales Outstanding | 0.19 | 0.70 | 7.25 | 12.01 | 4.42 |
| Days of Inventory Outstanding | 6.54 | 44.37 | 9.52 | 83.67 | 145.04 |
| Days of Payables Outstanding | 124.57 | 37.21 | 139.32 | 211.16 | 331.02 |
| Operating Cycle | 6.73 | 45.07 | 16.77 | 95.68 | 149.46 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -135.51 | -62.14 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -135.51 | -62.14 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.46 | -1.62 | -0.44 | -0.30 | -0.00 |
| Operating Cash Flow to Sales Ratio | -1.72 | -2.97 | -0.84 | -0.45 | -0.00 |
| Free Cash Flow Yield | -59.99% | -19.38% | -20.26% | -24.78% | -0.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.90 | -1.25 | -1.75 | -4.60 | -12.28 |
| Price-to-Sales (P/S) Ratio | 2.88 | 15.58 | 4.15 | 1.80 | 1.60 |
| Price-to-Book (P/B) Ratio | -0.60 | -7.79 | -1.73 | -0.91 | -1.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.67 | -5.16 | -4.94 | -4.04 | -573.34 |
| Price-to-Operating Cash Flow Ratio | -1.68 | -5.24 | -4.94 | -4.04 | -573.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.01 | -0.00 | 0.07 | 0.17 |
| Enterprise Value Multiple | -2.11 | -1.40 | -2.46 | -3.63 | -6.57 |
| Enterprise Value | 4.78M | 18.14M | 7.60M | 3.83M | 2.81M |
| EV to EBITDA | -2.11 | -1.40 | -2.46 | -3.63 | -6.57 |
| EV to Sales | 6.42 | 17.34 | 5.45 | 3.29 | 2.76 |
| EV to Free Cash Flow | -3.71 | -5.75 | -6.48 | -7.40 | -990.65 |
| EV to Operating Cash Flow | -3.74 | -5.84 | -6.48 | -7.40 | -990.65 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.58 | -0.52 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Income Per Share | -0.00 | -0.01 | -0.01 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.52 |
| Interest Burden | 1.05 | 1.01 | 1.07 | 0.43 | 0.20 |
| Research & Development to Revenue | 0.07 | 0.37 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.18 | 12.19 | 2.58 | 1.02 | 0.61 |
| Stock-Based Compensation to Revenue | 0.40 | 9.60 | 1.30 | 2.24 | 0.00 |
| Income Quality | 0.54 | 0.24 | 0.35 | 1.14 | 0.03 |
Currency in USD